This review outlines the progress made so far in understanding the biology of remyelination, what goes wrong in multiple sclerosis, some of the research problems that need to be tackled and the prospect for treatments in the not-too-distant future.

As the final data from the MS Risk-Sharing scheme (RSS) is published in the BMJ, we reflect on how this pioneering scheme has changed the landscape for people living with MS.

Chris Wasey gives his account of what it’s like to receive HSCT (stem cell transplant) on the NHS and the impact it had on his MS.

If your MS symptoms feel worse at night, you're not alone. Here's why that might be, and what you can do about it.

The Risk-sharing Scheme is the Scheme that was introduced in 2002 to ensure the availability of the first line disease modifying drug therapies - beta interferon and glatiramer acetate - on the NHS to people with certain types of multiple sclerosis.

Are covid vaccines safe and effective for people with multiple sclerosis (MS)? When should I book my booster? Am I eligible for a third dose of covid vaccine?

Some people taking medication may make antibodies against that drug, reducing or neutralising the drug's effectiveness.

Multiple sclerosis is often diagnosed in women at a time when they’re considering starting a family. Many women, and their partners, will have questions around the impact of MS on pregnancy and vice versa. To answer some of these questions, we spoke to consultant neurologist, Ruth Dobson who is one of the experts involved in developing pregnancy care guidelines for women with MS.

This study looked at whether taking one of the beta interferon disease modifying drugs extended life expectancy.